| 产品名称 | Peptides EP11397_1 | PRAME 300–309 (HLA-A*02:01) |
|---|---|
| 目录号 | EP11397_1 |
| 别名 | PRAME 300–309 (HLA-A*02:01) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP11397_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP11397_1 | PRAME 300–309 (HLA-A*02:01)
品名：PRAME 300–309 (HLA-A*02:01)
货号：EP11397_1
规格：1 mg; 5 mg
品牌：Peptides.de
产品描述
ALYVDSLFFL is a linear peptidic epitope (epitope ID225231) studied as part of Melanoma antigen preferentially expressed in tumors from Homo sapiens (human), tested in T cell assays. Antigen Peptide PRAME 300–309 (HLA-A*02:01) ALYVDSLFFL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
| Protein | Melanoma antigen preferentially expressed in tumors |
| Species | Human |
| Application | Flow Cytometry |
| Indication | Cancer |
